Activated CAR-NK cells kill tumors through multiple effector mechanisms: releasing perforin and granzymes to directly induce tumor cell apoptosis; expressing FasL and TRAIL to trigger apoptosis of target cells via death receptor pathways; and engaging in antibody-dependent cellular cytotoxicity (ADCC) to kill tumor cells (34, 35). This evidence concerns the gene PRF1 and neoplasm.